Featured News
Microfinance vs. Biotechnology: Defining Success and Failure
By Dennis Shaughnessy When I think of the gap between theory and field in microfinance, and in the definition of success or failure in alleviating poverty, the comparison that comes to mind is with new cancer drugs developed by biotechnology companies. Amgen vs. ACCION, Genentech vs. Grameen, if you will. Read more…